Reaction

Reactive Capillary Endothelial Proliferation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 54 reports · 1 co-occurring drugs

As of the last recalculation, Reactive Capillary Endothelial Proliferation appears in 54 FAERS reports alongside 1 co-occurring drug terms. The strongest observed disproportionality signal is ATEZOLIZUMAB (PRR 187.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Atezolizumab	14	187.2	187.3

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.